Diagnosis of Microcrystalline Arthropathy;Diagnóstico de artropatía microcristalina

Reumatologia Clinica

Volumn 4, Issue SUPPL. 2, 2008, Pages 45-49

  Pascual, Eliseo ^a   Sivera, Francisca ^b  

^a Sección de Reumatología Hospital General Universitario   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Calcium pyrophosphate arthropathy; Gout; Sinovial

Indexed keywords

EID: 63649103411     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(08)76168-0     Document Type: Article

References (49)

1. Pascual E., and Sivera F. Why is gout so poorly managed?. Ann Rheum Dis 66 (2007) 1269-1270
2. Perez-Ruiz F., Pascual E., Carmona L., Gonzalez-Gay M.A., De Miguel E., Ureña I., et al. Diagnosis of gout in the rheumatology, hospital-based setting lies far from that recommended: results from the GEMA (Gout Evaluation of Management) Study. Arthritis Rheum 56 (2007) S639
3. Bolamaski I.S., and Schumacher H.R. Podagra is more than gout. Bull Rheum Dis 34 (1984) 1-8
4. Sivera F., Aragón R., and Pascual E. First metatarsophalangeal joint aspiration using a 29-Gauge needle. Ann Rheum Dis 67 (2008) 273-275
5. Barthélémy I., Karanas Y., Sannajust J.P., Emering C., and Mondié J.M. Gout of the temporomandibular joint: pitfalls in diagnosis. J Craniomaxillofac Surg 29 (2001) 307-310
6. De Santis D., Palazzi C., D'Amico E., Di Mascio D.E., Pace-Palitti V., and Petricca A. Acromioclavicular cyst and 'porcupine shoulder' in gout. Rheumatology 40 (2001) 1320-1321
7. Currey H. Primary gout affecting the sternoclavicular joint. Br Med J 1 (1976) 583-584
8. Kernodle Jr. G.W., and Allen N.B. Acute gout presenting in the manubriosternal joint. Arthritis Rheum 29 (1986) 570-572
9. Kerr R. Radiologic case study. Sacroiliac joint involvement by gout and hyperparathyroidism. Orthopedics 11 (1988) 187-190
10. Gardner H., and McQueen F. Tophaceous gout of the pubic symphysis: an unusual cause of groin pain. Ann Rheum Dis 63 (2004) 767-768
11. Parhami N., and Feng H. Gout in the hip joint. Arthritis Rheum 36 (1993) 1026
12. Nakajima A., Kato Y., Yamanaka H., Ito T., and Kamatani N. Spinal tophaceous gout mimicking a spinal tumor. J Rheumatol 31 (2004) 1459-1460
13. Weinzweig J., Fletcher J.W., and Linburg R.M. Flexor tendinitis and median nerve compression caused by gout in a patient with rheumatoid arthritis. Plast Reconstr Surg 106 (2000) 1570-1572
14. Nelson C., Haines Jr. J.D., and Harper III C.A. Gout presenting as a popliteal cyst. A case of pseudothrombophlebitis. Postgrad Med 82 (1987) 73-74
15. Ravi Kumar A.S., Bui C., Szwarc G., and Dixson H. Florid polyarticular gout mimicking septic arthritis. Clin Nucl Med 29 (2004) 262-263
16. Suk K.S., Kim K.T., Lee S.H., Park S.W., and Park Y.K. Tophaceous gout of the lumbar spine mimicking pyogenic discitis. Spine J 7 (2007) 94-99
17. Kostman J.R., Rush P., and Reginato A.J. Granulomatous tophaceous gout mimicking tuberculous tenosynovitis: report of two cases. Clin Infect Dis 21 (1995) 217-219
18. Schapira D., Stahl S., Izhak O.B., Balbir-Gurman A., and Nahir A.M. Chronic tophaceous gouty arthritis mimicking rheumatoid arthritis. Semin Arthritis Rheum 29 (1999) 56-63
19. Nakajima A., Kato Y., Yamanaka H., Ito T., and Kamatani N. Spinal tophaceous gout mimicking a spinal tumor. J Rheumatol 31 (2004) 1459-1460
20. Campion E.W., Glyn R.J., and De Labry L.O. Asymptomatic hyperuricemia. Am J Med 82 (1987) 421-426
21. Park Y.B., Park Y.S., Lee S.C., Yoon S.J., and Lee S.K. Clinical analysis of gouty patients with normouricaemia at diagnosis. Ann Rheum Dis 62 (2003) 90-92
22. Urano W., Yamanaka H., Tsutani H., Nakajima H., Matsuda Y., Taniguchi A., et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 29 (2002) 1950-1953
23. Wallace S.L., Robinson H., Masi A.T., Decker J.L., McCarty D.J., and Yü T.F. Preliminary criteria for the classificaction of the acute arthritis of primary gout. Arthritis Rheum 20 (1977) 895-900
24. Malik A., Schumacher H.R., Dinnella J., and Clayburne G.M. Validation of gout clinical diagnostic criteria in VA patients compared with gold standard of synovial fluid analysis. Arthritis Rheum 56 (2007) S639
25. Hunder G.G. The use and missuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 129 (1998) 417-418
26. Bloch D.A., Moses L.E., and Michel D.A. Statiscical approaches to classification. Methods for developing classification and other criteria rules. Arthritis Rheum 33 (1990) 1137-1144
27. Shah K., Spear J., Nathanson L.A., McCauley J., and Edlow J.A. Does the presence of crystal arthritis rule out septic arthritis?. J Emerg Med 32 (2007) 23-26
28. Resnick D., Williams G., Weisman M.H., and Slaughter L. Rheumatoid arthritis and pseudo-rheumatoid arthritis in calcium pyrophosphate dihydrate crystal deposition disease. Radiology 140 (1981) 615-621
29. Pego-Reigosa J.M., Rodríguez-Rodriguez M., Hurtado-Hernandez Z., Gromaz-Martin J., Taboas-Rodriguez D., Millan-Cachinero C., et al. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Arthritis Rheum 53 (2005) 931-938
30. Grassi W., Menga G., Pascual E., and Filipucci E. "Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum 36 (2006) 197-202
31. Donich A.S., Lektrakul N., Liu C.C., Theodorou D.J., Kakitsubata Y., and Resnick D. Calcium pyrophosphate dihydrate crystal deposition disease of the wrist: trapezioscaphoid joint abnormality. J Rheumatol 27 (2000) 2628-2634
32. Baysal T., Baysal O., Kutlu R., Karaman I., and Mizrak B. The crowned dens syndrome: a rare form of calcium pyrophosphate deposition disease. Eur Radiol 10 (2000) 1003-1005
33. Chollet-Janin A., Finckh A., Dudler J., and Guerne P.A. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum 56 (2007) 688-692
34. Zhang W., Doherty M., Bardin T., Pascual E., Barskova V., Conaghan P., et al. EULAR Evidence based recommendations for gout - part ii management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 25 (2006) 1301-1311
35. Yü T.-F., and Gutman A.B. Mobilization of gouty tophi by protracted use of uricosuric agents. Am J Med 11 (1951) 765-769
36. Li-Yu J., Clayburne G., Sieck M., Beutler A., Rull M., Eisner E., et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?. J Rheumatol 28 (2001) 577-580
37. Pascual E., Batlle-Gualda E., Martínez A., Rosas J., and Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 131 (1999) 756-759
38. Pascual E., and Sivera F. The time required for disappearance of urate crystals from synovial fluid after successful hypouricemic treatment relates to the duration of gout. Ann Rheum Dis 97 (2007) 273-275
39. Pascual E., and Jovani V. Synovial fluid analysis. Best Pract Res Clin Rheumatol 19 (2005) 371-386
40. Lumbreras B., Pascual E., Frasquet J., González-Salinas J., Rodríguez E., and Hernández-Aguado I. Analysis for crystals in synovial fluid: training of the analysts results in high consistency. Ann Rheum Dis 64 (2005) 612-615
41. McCarty D.J., and Hollander J.L. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 54 (1961) 452-460
42. Schumacher R.J., Jiménez S., Gibson T., Pascual E., Traycoff R., Dorwart B., et al. Acute gouty arthritis without urate crystals identified on initial examination of synovial fluid report of nine patients. Arthritis Rheum 18 (1975) 603-612
43. Pascual E. Persistence of monosodium urate crystals, and low grade inflammation in the synovial fluid of untreated gout. Arthritis Rheum 34 (1991) 141-145
44. Perez-Ruiz F., Calabozo M., Pijoan J.I., Herrero-Beites A.M., and Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 47 (2002) 356-360
45. Ivorra J., Rosas E., and Pascual E. Most calcium pyrophosphate crystals appear as non-birefringent. Ann Rheum Dis 58 (1999) 582-584
46. Martinez-Sanchis A., and Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis 64 (2005) 1769-1772
47. Nalbant S., Martinez J.A., Kitumnuaypong T., Clayburne G., Sieck M., and Schumacher Jr. H.R. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 11 (2003) 50-54
48. Grassi W., Meenagh G., Pascual E., and Filippucci E. "Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum 36 (2006) 197-202
49. Wright S.A., Filippucci E., McVeigh C., Grey A., McCarron M., Grassi W., et al. High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study. Ann Rheum Dis 66 (2007) 859-864